Cerevance Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

Cerevance Inc (Cerevance) is a pharmaceutical company that strives to develop medicines for the treatment of neurological and psychiatric diseases. It is also developing preclinical and clinical programs for Parkinsons disease, L-Dopa induced dyskinesia, cognitive impairment, neuroinflammation and anxiety. The company harnesses its technology platform to reveal the molecular properties of each brain cell type in human tissue. Cerevance aims to develop new therapies targeting antibodies, small-molecules, and other modalities. It is also measuring glial cells across the brain which plays a role in diseases involving neuro-inflammation. The company has presence in the US and the UK. Cerevance is headquartered in Boston, Massachucets, the US.

Cerevance Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

It derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 4
List of Figures 4
Cerevance Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Cerevance Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Cerevance Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Cerevance Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Cerevance Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Cerevance Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Cerevance Raises USD5 Million in Financing 10
Cerevance Raises USD21.5 Million in Series A Financing 11
Licensing Agreements 12
Cerevance Enters into Licensing Agreement with Rockefeller University 12
Cerevance Inc - Key Competitors 13
Cerevance Inc - Key Employees 14
Cerevance Inc - Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Recent Developments 16
Corporate Communications 16
Oct 09, 2018: Cerevance Appoints Ted Hibben as Chief Business Officer 16
Nov 27, 2017: Cerevance Appoints David H. Margolin, MD, PhD as Senior Vice President of Clinical and Translational Medicine 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List Of Tables


Cerevance Inc, Pharmaceuticals & Healthcare, Key Facts 2
Cerevance Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Cerevance Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Cerevance Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Cerevance Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Cerevance Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Cerevance Raises USD5 Million in Financing 10
Cerevance Raises USD21.5 Million in Series A Financing 11
Cerevance Enters into Licensing Agreement with Rockefeller University 12
Cerevance Inc, Key Competitors 13
Cerevance Inc, Key Employees 14
Cerevance Inc, Other Locations 15

List Of Figures


Xinjiang Goldwind Science & Technology Co Ltd, Performance Chart (2013 - 2017) 31
Xinjiang Goldwind Science & Technology Co Ltd, Ratio Charts 33
Xinjiang Goldwind Science & Technology Co Ltd, Power, Deals By Year, 2012 to YTD 2018 34
Xinjiang Goldwind Science & Technology Co Ltd, Power, Deals by Type, 2012 to YTD 2018 35

Cerevance Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Cerevance Inc (Cerevance) is a pharmaceutical company that strives to develop medicines for the treatment of neurological and psychiatric diseases. It is also developing preclinical and clinical programs for Parkinsons

USD 250 View Report

Kansas Electric Power Cooperative Inc - Strategic SWOT Analysis Review

Kansas Electric Power Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the companys history, corporate strategy, business structure and operations. The report contains a detailed SWOT

USD 125 View Report

WPPI Energy Inc - Strategic SWOT Analysis Review

WPPI Energy Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the companys history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information

USD 125 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available